Skip to content

Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19

Effects of Interventions and Lifestyle Modifications in Integrative Medicine and the Course of Infectious Respiratory Diseases Including COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04653727
Acronym
AtemNHK
Enrollment
1287
Registered
2020-12-04
Start date
2021-01-06
Completion date
2021-03-05
Last updated
2022-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Influenza A, Respiratory Disease

Brief summary

The outbreak of the novel coronavirus SARS-CoV-2 caused a health emergency of international proportions when it was declared by the World Health Organization (WHO) in January 2020. Since then, the virus has spread internationally and the WHO has classified the outbreak as a pandemic. In the context of the increasing reporting of this pandemic and the increasing governmental measures to limit or slow down the spread of SARS-CoV-2 by all means, there is so far little scientific evidence for the effects of a healthy lifestyle on the disease. The aim of this study is to compare the potential of different, possibly protective lifestyles using the example of the COVID-19 pandemic. We will conduct an online survey with 3.000 participants using mobile website technology.

Interventions

No intervention.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

\- Present declaration of consent

Exclusion criteria

\- Lack of consent to participate in the study

Design outcomes

Primary

MeasureTime frame
SARS-CoV-2 infectionAssessed retrospectively (last 6 months) with self-designed question

Secondary

MeasureTime frameDescription
Use of anthroposophic medicineAssessed retrospectively (last 6 months) with self-designed question
Use of digital health servicesAssessed retrospectively (last 6 months) with self-designed question
Use of phytotherapyAssessed retrospectively (last 6 months) with self-designed question
Use of dietary supplementsAssessed retrospectively (last 6 months) with self-designed question
Influenza virus infectionAssessed retrospectively (last 6 months) with self-designed question
Other respiratory infectionsAssessed retrospectively (last 6 months) with self-designed question
Dietary habitsAssessed retrospectively (last 6 months) with self-designed question
Sports activityAssessed retrospectively (last 6 months) with self-designed question
Time spent in natureAssessed retrospectively (last 6 months) with self-designed question
WHO-5 Well-Being IndexAssessed when filling out the questionnaire (Baseline)The scale ranges from 0 to 100, where 0 is the lowest level of well-being / lowest quality of life and 100 is the highest level of well-being / highest quality of life.
Numeric analog scale (NAS) stressAssessed retrospectively (last 6 months) with self-designed questionThe NAS ranges from 0 to 10, where 0 is the lowest level of stress and 10 is the highest level of stress.
Numeric analog scale (NAS) anxietyAssessed retrospectively (last 6 months) with self-designed questionThe NAS ranges from 0 to 10, where 0 is the lowest level of anxiety and 10 is the highest level of anxiety.
Numeric analog scale (NAS) depressionAssessed retrospectively (last 6 months) with self-designed questionThe NAS ranges from 0 to 10, where 0 is the lowest level of anxiety and 10 is the highest level of anxiety.
Use of relaxation / mind body approachesAssessed retrospectively (last 6 months) with self-designed question
Alcohol consumptionAssessed retrospectively (last 6 months) with self-designed question
Cigarette consumptionAssessed retrospectively (last 6 months) with self-designed question
Self-efficacyAssessed when filling out the questionnaire (Baseline)The scale ranges from 0 to 100, where 0 is the lowest level of self-efficacy and 100 is the highest level of self-efficacy.
Sick leaveAssessed retrospectively (last 6 months) with self-designed question
Use of hydrotherapy/Kneipp applicationsAssessed retrospectively (last 6 months) with self-designed question

Other

MeasureTime frame
Qualitative interviewsConducted 1 month after completion of the questionnaire (once)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026